Shinichiro Shinzaki

29PUBLICATIONS
129CO-AUTHORS
Predictive and prognostic markersDiagnostic radiographyEpigenetics (incl. genome methylation and epigenomics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Dec 22, 2025
Post-marketing Surveillance of Tofacitinib in Patients With Ulcerative Colitis in Japan: A Post Hoc Analysis of Safety and Effectiveness by Prior Biologic Status.

Katsuyoshi Matsuoka, Satoshi Motoya, Shinichiro Shinzaki

|Nov 28, 2025
Initial Treatment Failure as a Predictor of Proximal Extension in Patients with Newly Diagnosed Limited Ulcerative Colitis: A Retrospective Cohort Study with Propensity Score-Matched Analysis.

Toshiyuki Sato, Jiro Takeuchi, Kazuko Nagase

|Nov 27, 2025
Long-Term Outcomes After Therapeutic Induction in Patients with Functional Dyspepsia.

Takayuki Kitano, Toshihiko Tomita, Masatoshi Mieno

|Oct 16, 2025
Effect of Chronic Social Defeat Stress on the Small-Intestinal Environment, Including the Gut Flora, Immune System, and Mucosal Barrier Integrity.

Soichi Yagi, Hirokazu Fukui, Tetsuya Shiraishi

|Aug 14, 2025
Comparative Effectiveness of Ustekinumab and Vedolizumab as Maintenance Therapy After Tacrolimus-Induced Improvement in Patients with Acute Severe Ulcerative Colitis: A Retrospective Cohort Study.

Koji Kaku, Toshiyuki Sato, Jiro Takeuchi

|Jul 18, 2025
OTUD3 prevents ulcerative colitis by inhibiting microbiota-mediated STING activation.

Bo Li, Taiki Sakaguchi, Haruka Tani

Pageof 5

Frequent Collaborators

6 joint publications

Toshiyuki Sato

6 joint publications

Tetsuo Takehara

6 joint publications

Toshihiko Tomita

5 joint publications

Yoshito Hayashi